title: Optimal management of steroid-dependent ulcerative colitis.
abstract: Ulcerative colitis (UC) is a chronic inflammatory condition that is variable in both extent and severity of disease as well as response to therapy. Corticosteroids (CSs) were the first drugs used in the management of UC and are still used for induction of remission. However, because of their extensive side-effect profile, they are not utilized for maintenance of remission. In view of this, CS-free remission has become an important end point while evaluating therapeutic agents used in the management of UC. This review highlights the results of various studies conducted to evaluate the efficacy of different medications to attain CS-free remission in the setting of active UC. The drugs reviewed include established agents such as thiopurines, methotrexate, infliximab, adalimumab, vedolizumab, golimumab, and newer experimental agents, and if all else fails, colectomy will be performed. The efficacy of these drugs is evaluated individually. Our aim is to provide a synopsis of the work done in this field to date.
authors.affiliation: Department of Medicine, King Edward Medical University, Lahore, Pakistan.
authors.forename: Hafiz M Waqas
authors.initials: HM
authors.lastname: Khan
authors.affiliation: Department of Medicine, King Edward Medical University, Lahore, Pakistan.
authors.forename: Faisal
authors.initials: F
authors.lastname: Mehmood
authors.affiliation: Section of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia VA Medical Center, Philadelphia, PA, USA.
authors.forename: Nabeel
authors.initials: N
authors.lastname: Khan
keywords: MTX; adalimumab; infliximab; steroid dependent; thiopurines; ulcerative colitis